4-Bromo-2-fluoropyridine | CAS:128071-98-7

We serve 4-Bromo-2-fluoropyridine CAS:128071-98-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromo-2-fluoropyridine

Chemical Name:  4-Bromo-2-fluoropyridine
CAS.NO: 128071-98-7
Synonyms: 2-Fluoro-4-bromopyridine
Molecular Formula: C5H3BrFN
Molecular Weight: 175.98600
 
Physical and Chemical Properties:
Density: 1.7±0.1 g/cm3
Melting point: /
Boiling point: 195.9±20.0 °C at 760 mmHg
Flash point: 72.3±21.8 °C
Index of Refraction: 1.534
 
Specification:
Appearance: Colorless to light yellow liquid
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate



Contact us for information like 4-Bromo-2-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Fluoro-4-bromopyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-4-bromopyridine Use and application,4-Bromo-2-fluoropyridine technical grade,usp/ep/jp grade.


Related News: A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.4-Amino-3-nitrophenol manufacturer A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.Thymidine 5'-Triphosphate Sodium Salt supplier The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.2-Methoxy-5-methylpyridine vendor The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.